Prosecution Insights
Last updated: April 19, 2026

Editforce Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18557146 THERAPEUTIC DRUG FOR MYOTONIC DYSTROPHY TYPE 1 KELLY, ROBERT M 1638 Non-Final OA Oct 25, 2023
17915232 METHOD FOR EDITING TARGET RNA SHEN, WU CHENG WINSTON 1682 Final Rejection Sep 28, 2022

Managing Editforce Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month